| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/02/2000 | CA2020838C Hemoregulatory peptides |
| 05/02/2000 | CA2017636C Derivative of tissue-type plasminogen activator |
| 05/02/2000 | CA2012170C Novel method of ovulation induction in humans |
| 05/02/2000 | CA2011878C Immunogenic regions on the e7 protein of human papillomavirus type 16 |
| 05/02/2000 | CA1340982C Protamine-reactive igm antibodies |
| 05/02/2000 | CA1340978C Purification, cloning and characterization of the gene for interleukin 1 |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023625A2 Isolated nucleic acid molecules which encode scp proteins, and uses thereof |
| 04/27/2000 | WO2000023621A2 Visualization of rna in living cells |
| 04/27/2000 | WO2000023610A1 Method for screening compound inhibiting signal transduction of inflammatory cytokine |
| 04/27/2000 | WO2000023604A1 Expression vectors containing regulative sequences of stylonychia lemnae for heterologous protein expression in eukaryotic protists and a method for identifying regulative sequences of this type |
| 04/27/2000 | WO2000023602A2 Regulated expression using conditional er retention domains |
| 04/27/2000 | WO2000023600A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | WO2000023599A2 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | WO2000023595A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/27/2000 | WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 04/27/2000 | WO2000023593A2 Molecular pathogenicide mediated plant disease resistance |
| 04/27/2000 | WO2000023591A2 Secreted protein zsig49 |
| 04/27/2000 | WO2000023590A2 INHIBITION OF CD40-MEDIATED NFλB ACTIVATION |
| 04/27/2000 | WO2000023589A2 Proliferation and apoptosis related proteins |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023587A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 04/27/2000 | WO2000023586A1 HUMAN PROTEIN Grf40 AND cDNA THEREOF |
| 04/27/2000 | WO2000023585A1 Cardiac troponin i polypeptide fragments and uses in diagnostics |
| 04/27/2000 | WO2000023584A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 04/27/2000 | WO2000023583A2 p53 BINDING AREAS |
| 04/27/2000 | WO2000023580A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | WO2000023578A2 Methods of suppressing flowering in transgenic plants |
| 04/27/2000 | WO2000023575A1 Ups (ugc) |
| 04/27/2000 | WO2000023573A2 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023569A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023476A1 Neovascular-specific peptides |
| 04/27/2000 | WO2000023475A1 Intracellular c-terminal hdl-receptor domain |
| 04/27/2000 | WO2000023474A1 Protein engineering |
| 04/27/2000 | WO2000023473A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | WO2000023472A2 Interferon-beta fusion proteins and uses |
| 04/27/2000 | WO2000023471A2 Use of a cytokine-producing lactococcus strain to treat colitis |
| 04/27/2000 | WO2000023470A1 Isolated proteins and nucleic acid molecules having homology to the nip2 protein and uses thereof |
| 04/27/2000 | WO2000023469A2 Fragments of insulin-like growth factor binding protein and insulin-like growth factor, and uses thereof |
| 04/27/2000 | WO2000023468A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES |
| 04/27/2000 | WO2000023467A1 birA |
| 04/27/2000 | WO2000023466A2 Human rna binding proteins |
| 04/27/2000 | WO2000023464A2 Zinc finger binding domains for gnn |
| 04/27/2000 | WO2000023463A2 Fluorescent dye binding peptides |
| 04/27/2000 | WO2000023459A1 Inhibitors of platelet activation and recruitment |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023111A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023110A1 Methods and agents for inducing apoptosis and methods for their identification |
| 04/27/2000 | WO2000023109A1 Glypicans for the detection and treatment of human carcinoma |
| 04/27/2000 | WO2000023108A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023098A1 Stable concentrated insulin preparations for pulmonary delivery |
| 04/27/2000 | WO2000023096A2 Combination therapy with vip antagonist |
| 04/27/2000 | WO2000023094A2 Methods of inhibiting platelet activation and recruitment |
| 04/27/2000 | WO2000023092A1 Contulakin-g, analogs thereof and uses therefor |
| 04/27/2000 | WO2000023087A1 Polyspecific binding molecules and uses thereof |
| 04/27/2000 | WO2000023083A1 Neuroprotective truncated bax polypeptides |
| 04/27/2000 | WO2000023082A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000022932A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 04/27/2000 | WO2000022929A1 Gene transfer of human e2f-1 to inhibit vascular smooth muscle cell growth |
| 04/27/2000 | WO2000008149A3 Human neuronal acid-sensitive cationic channels, its cloning and applications |
| 04/27/2000 | WO2000007014A3 Leptin-mediated gene-induction |
| 04/27/2000 | WO2000006754A3 Engineering nematode resistance in solanacae |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000005377A3 Pc4 transcriptional coactivators |
| 04/27/2000 | WO2000005255A3 Anti-inflammatory compounds |
| 04/27/2000 | WO2000004919A3 Live attenuated salmonella vaccines to control avian pathogens |
| 04/27/2000 | WO2000004383A3 Hiv group o positive control |
| 04/27/2000 | WO2000004167A3 Genes encoding sulfate assimilation proteins |
| 04/27/2000 | WO2000004152A3 Androgen receptor coactivators |
| 04/27/2000 | WO2000001732A3 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/27/2000 | WO1999067382A3 Angiopoietin-like growth factor sequences |
| 04/27/2000 | WO1999067282A3 Olfactory receptors and their uses |
| 04/27/2000 | WO1999064586A3 Phagocytic assay method |
| 04/27/2000 | WO1999064439A3 Methods for increasing cationic antimicrobial peptides |
| 04/27/2000 | WO1999057271A9 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 04/27/2000 | WO1999055844A3 Methods for modulating differentiation |
| 04/27/2000 | WO1999050406A9 Growth differentiation factor-9 regulatory sequences and uses therefor |
| 04/27/2000 | WO1999006544A8 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 04/27/2000 | WO1998056811A8 Plant grab proteins |
| 04/27/2000 | DE19849283A1 New fragments of integral membrane proteins, used e.g. to screen for therapeutic agents for Alzheimer's or Parkinson's diseases, are particularly from bacteriorhodopsin |
| 04/27/2000 | DE19849073A1 Transgene encoding amyloid precursor protein or its fragment, used to produce transgenic nematodes used, e.g. to screen for agents for treating Alzheimer's disease |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19848785A1 New thrombin inhibiting protein useful for diagnosis, treatment and prevention of thromboembolic diseases, is obtained from Dipetalogaster maximus |
| 04/27/2000 | DE19848517A1 Controlling phytopathogenic fungi, useful particularly against Botrytis cinerea resistant to known fungicides, by treatment with peptide from Streptomyces tendae |
| 04/27/2000 | DE19847142A1 Diagnosing borelliosis by detecting specific antibodies, using new Borellia antigens expressed preferentially during infection and also useful as immunogens in vaccines |
| 04/27/2000 | DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes |
| 04/27/2000 | DE19831429A1 Preparation and identification of polytopic peptide, useful e.g. therapeutically and for detecting antigens or antibodies, by linking fragments of a protein and testing for specific binding |
| 04/27/2000 | CA2749553A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | CA2633345A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | CA2622786A1 Neovascular-specific peptides |
| 04/27/2000 | CA2364330A1 Secreted protein zsig49 |
| 04/27/2000 | CA2354862A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 04/27/2000 | CA2348156A1 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | CA2348153A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | CA2347917A1 Protein engineering |